Intermittent Pneumatic CompressionNCT06636942
Effects of Intermittent Pneumatic Compression Following an Officiall Soccer Match
A study testing Intermittent pneumatic compression in people with Intermittent Pneumatic Compression and Placebo - Control, run by University of Maia at 1 site in Portugal.
Trial summary
This study aims to identify the effects of the use of intermittent pneumatic compression on the recovery kinetics following an official soccer match, in comparision with a placebo condition. Read more about this study
- Who is it for?
- Ages 18 to 20 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Intermittent Pneumatic Compression, Placebo - Control
- What is being tested?
- Intermittent pneumatic compression
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 40 participants
- Where
- 1 sitePortugal
- Study dates
- 1 Oct 2024to 29 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 20 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- elite soccer players
Who cannot join
- absent from injuries
- playing less than 70 minutes
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Intermittent Pneumatic Compression Following an Officiall Soccer Match on Elite Youth Soccer Players
This study aims to identify the effects of the use of intermittent pneumatic compression on the recovery kinetics following an official soccer match, in comparision with a placebo condition. Participants will perform neuromuscular tests (ie, cmj, low-frequency fatigue), respond to perception scales (RPE, perceived fatigue, soreness, sleep), and biochemical tests (CK analysis). These assessments will be carried out before the match, 30 minutes post match, at the 24th and 48th hour.
- Being tested
- Intermittent pneumatic compression
- Keywords
- sports, recovery, athletic performance, soccer
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intermittent pneumatic compressionDevice
Following a soccer match, athletes will be enrolled in a recovery treatment: placebo intervention or intermittent pneumatic compression. Participants will be randomly assigned to each group. Neuromuscular tests (cmj) and perceptual questionnaires (hooper index) will be conducted.
| Study group | Role | What they receive |
|---|---|---|
| Intermittent pneumatic compression | Experimental | 30 minutes of intermittent pneumatic compression at 200mmHg Receives: Device: Intermittent pneumatic compression |
| Placebo | Placebo comparator | A hydrant cream on a pad will be placed on participants quadriceps stating that they are using an inovative recovery cream. Receives: Device: Intermittent pneumatic compression |
What is being measured
The primary outcome is the main question the study is designed to answer.
Countermovement jump height
Height measure using CMJ test
Measured: 30 minute, 24 hour, 48 hour
low-frequency fatigue
LFF measured using Myocene (Liege, Belgium)
Measured: baseline, 30 minute, 24 hour, and 48 hour
creatine-kinase
Muscle damage asses using the biomarker CK
Measured: baseline, 24 hour, and 48 hour
Hooper index
Application of the hooper index questionnaire
Measured: baseline, 30 minute, 24 hour, and 48 hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Oct 2024
- Study start1 Oct 2024
- Primary completion29 May 2025
- Study completion29 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Intermittent Pneumatic CompressionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Maia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Filipe Silvano Pinto Maia, University of Maia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06636942
- Sponsor's protocol ID
- PDFM_004
- Status last verified
- Jun 2025
- First submitted
- 2 Oct 2024
- Last updated
- 3 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Maia F, Tito S, Correia M, Nakamura FY, Ribeiro J. Intermittent pneumatic compression does not improve post-match neuromuscular, biochemical or perceptual recovery in international-level youth soccer players: a randomized placebo-controlled trial. BMC Sports Sci Med Rehabil. 2026 Feb 9;18(1):126. doi: 10.1186/s13102-026-01580-5.
PubMed 41656279
Study at a glance
From the registry record, last updated by the sponsor on 3 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Intermittent Pneumatic Compression Following an Officiall Soccer Match on Elite Youth Soccer Players
- ClinicalTrials.gov ID
- NCT06636942
- Acronym / sponsor ID
- PDFM_004
- Keywords
- sports, recovery, athletic performance, soccer
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- University of MaiaUniversity, hospital or other
- Study start
- 1 Oct 2024 (actual)
- Primary completion
- 29 May 2025 (actual)
- Study completion
- 29 Jun 2025 (actual)
- First posted
- 15 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to identify the effects of the use of intermittent pneumatic compression on the recovery kinetics following an official soccer match, in comparision with a placebo condition. Participants will perform neuromuscular tests (ie, cmj, low-frequency fatigue), respond to perception scales (RPE, perceived fatigue, soreness, sleep), and biochemical tests (CK analysis). These assessments will be carried out before the match, 30 minutes post match, at the 24th and 48th hour.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intermittent pneumatic compression | Experimental | Device: Intermittent pneumatic compression30 minutes of intermittent pneumatic compression at 200mmHg |
| Placebo | Placebo comparator | Device: Intermittent pneumatic compressionA hydrant cream on a pad will be placed on participants quadriceps stating that they are using an inovative recovery cream. |
Who may qualify
- Ages
- 18 to 20 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- elite soccer players
Key exclusion criteria (2 listed)
- absent from injuries
- playing less than 70 minutes
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intermittent pneumatic compressionFollowing a soccer match, athletes will be enrolled in a recovery treatment: placebo intervention or intermittent pneumatic compression. Participants will be randomly assigned to each group. Neuromuscular tests (cmj) and perceptual questionnaires (hooper index) will be conducted. | Device | Intermittent pneumatic compression, Placebo |
Primary outcome
Countermovement jump height
Time frame: 30 minute, 24 hour, 48 hour
Height measure using CMJ test
low-frequency fatigue
Time frame: baseline, 30 minute, 24 hour, and 48 hour
LFF measured using Myocene (Liege, Belgium)
creatine-kinase
Time frame: baseline, 24 hour, and 48 hour
Muscle damage asses using the biomarker CK
Hooper index
Time frame: baseline, 30 minute, 24 hour, and 48 hour
Application of the hooper index questionnaire
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jul 2025.
- Derived from this study: PubMed 41656279Maia F, Tito S, Correia M, Nakamura FY, Ribeiro J. Intermittent pneumatic compression does not improve post-match neuromuscular, biochemical or perceptual recovery in international-level youth soccer players: a randomized placebo-controlled trial. BMC Sports Sci Med Rehabil. 2026 Feb 9;18(1):126. doi: 10.1186/s13102-026-01580-5.
- Individual participant dataSharing planned: Undecided
Related trials for Intermittent Pneumatic Compression
Recruiting
CRPS-Hand: Contrast + Compression vs Whirlpool
Complex Regional Pain Syndrome I (CRPS I)
Active, not recruiting
The Effects of Recovery Compression Boots on Blood Lactate Levels, Functional Movement, and Joint Ange of Motion in Collegiate Athletes.
Healthy Participants
Recruiting
Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL
Breast Cancer-Related Lymphedema, BCRL
Recruiting
Evaluating the Hemodynamic Performance of the VenAir Sequential Compression System
No Condition, Healthy Individuals, No Conditions, Aged 20-64
RecruitingObservational study
Non-invasive Venous Air Plethysmography Assessment of Venous Hemodynamics in Patients Suspected Deep Venous Obstruction Used in Conjunction With Intermittent Pneumatic Compression.
Deep Vein Thrombosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intermittent pneumatic compression in people with Intermittent Pneumatic Compression and Placebo - Control, run by University of Maia at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Countermovement jump height (time frame: 30 minute, 24 hour, 48 hour). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06636942, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2025.